• 1
    Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol 1997; 24: 4156.
  • 2
    Moreland LW, O'Dell JR. Glucocorticoids and rheumatoid arthritis: back to the future? Arthritis Rheum 2002; 46: 255363.
  • 3
    Van Everdigen AA, Jacobs JW, Siewertsz van Reesema DR, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease modifying properties, and side effects. Ann Intern Med 2002; 136: 112.
  • 4
    Conn DL. Resolved: low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis. Arthritis Rheum 2001; 45: 4627.
  • 5
    Saag KG. Resolved: low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis. Arthritis Rheum 2001; 45: 46871.
  • 6
    Pincus T, Sokka T, Stein CM. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful? Ann Intern Med 2002; 136: 768.
  • 7
    Saag KG. Glucocorticoid use in rheumatoid arthritis. Curr Rheumatol Rep 2002; 4: 21825.
  • 8
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 9
    Escalante A, del Rincon I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999; 42: 171221.
  • 10
    Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA–DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum 2002; 46: 14808.
  • 11
    Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 87181.
  • 12
    O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, et al. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 1991; 22: 115563.
  • 13
    Hiatt WR. Drug therapy: medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 160821.
  • 14
    Orces CH, del Rincon I, Abel MP, Escalante A. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum 2002; 47: 6772.
  • 15
    Rogers WH. Sg17: regression standard errors in clustered samples. Stata Technical Bulletin 1993; 1923.
  • 16
    Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 2nd ed. New York: Springer-Verlag; 2002.
  • 17
    Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 273745.
  • 18
    Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 13037.
  • 19
    Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46: 17149.
  • 20
    Wallberg-Jonsson S, Backman C, Johnson O, Karp K, Lunstrom E, Sundqvist KG, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597602.
  • 21
    Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 148997.
  • 22
    Del Rincon I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003; 48: 183340.
  • 23
    Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 5160.
  • 24
    Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 11526.
  • 25
    Young W, Gofman JW, Tandy R, Malamud N, Waters ES. The quantification of atherosclerosis. III. The extent of correlation of degrees of atherosclerosis within and between the coronary and cerebral vascular beds. Am J Cardiol 1960; 6: 3008.
  • 26
    Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Atheroscler Thromb 1994; 14: 2614.
  • 27
    O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23: 175260.
  • 28
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 1422.
  • 29
    Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 88492.
  • 30
    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 131724.
  • 31
    Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PW, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death. Arch Intern Med 2003; 163: 193942.
  • 32
    Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Atheroscler Thromb 1994; 14: 2614.
  • 33
    Emanuele MA, Buchanan BJ, Abraira C. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease. Diabetes Care 1981; 4: 28992.
  • 34
    Orchard TJ, Strandness DE Jr. Assessment of peripheral artery disease in diabetics: report and recommendation of an international workshop sponsored by the American Diabetes Association and the American Heart Association. Circulation 1993; 88: 81928.
  • 35
    Zierler RE, Sumner DS. Physiologic assessment of peripheral arterial occlusive disease. In: RutherfordRB, editor. Vascular surgery. Philadelphia: Saunders; 2000. p. 14065.
  • 36
    Monckeberg JG. Über die reine mediaverkalkung der extremitätenarterien und ihr verhalten zur arteriosklerose. Virchows Arch Pathol Anat Physiol Klin Med 1903; 171: 14167.
  • 37
    Leskinen Y, Salenius JP, Lehtimaki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirement for diagnostics. Am J Kidney Dis 2002; 40: 4729.
  • 38
    Maser RE, Wolfson SK Jr, Ellis D, Stein EA, Drash AL, Becker DJ, et al. Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arterioscler Thromb 1991; 11: 95865.
  • 39
    Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laasko M. Medial artery calcification: a neglected harbinger of cardiovascular complication in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 97883.
  • 40
    Kalbak K. Incidence of arteriosclerosis in patients with rheumatoid arthritis receiving long-term corticosteroid therapy. Ann Rheum Dis 1972; 3: 196200.
  • 41
    Zheng JJ, Sharrett AR, Chambless LE, Rosamong WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997; 131: 11525.
  • 42
    Stern MP, Kolterman OG, Fries JF, McDevitt HO, Reaven GM. Adrenocortical steroid treatment of rheumatic diseases: effects on lipid metabolism. Arch Intern Med 1973; 132: 97101.
  • 43
    Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 2000; 16: 50511.
  • 44
    Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 12608.
  • 45
    RothmanK, GreenlandS, editors. Generalizability. In: Precision and validity in epidemiologic studies. Philadelphia: Lippincott-Raven; 1998. p. 1334.